Sorrento Announces IND Filing for COVI-DROPS, an Intranasal Formulation of a High Potency Neutralizing Antibody Against SARS-CoV-2

NEXT STORY
Seasonal Probiotics Company Jetson Adds Leading Pediatrician and OBGYN to Advisory “Gut Council”
PREV STORY
Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hemispherx Biopharma Signs Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center to Study Ampligen in Combination with Checkpoint Inhibitors in a Phase IIa Study in Urothelial Carcinoma, Renal Cell Carcinoma and Melanoma

New Agreement Expands Existing Preclinical CollaborationsOCALA, Fla., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Hemispherx ...

author_avatar
NASDAQ Market News

FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review

author_avatar
NASDAQ Market News

Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada

author_avatar
NASDAQ Market News